Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722140 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Early Stage and Discovery Deals: Strategy, Structure and Payment Terms, 2nd Edition
Pharmalicensing Ltd., Dec 2006, Pages: 144


  Description  
  Table of Contents  
  Summary  
  Companies Mentioned  
    
   
 Enquire before Buying  
 Send to a Friend  

Today early-stage partnering is a core component of both biotech and pharmaceutical business strategy, allowing companies to access promising new and emerging compounds and technologies. To become a successful player within the life science industry it is crucial to understand the changing dynamics of the industry’s early stage deal-making trends.

Our revised second edition of “Early Stage and Discovery Deals: Strategy, Structure and Payment Terms” analyzes the early stage dealmaking trends and discusses the basics of dealmaking structures, covering payments terms and deal valuations. In-depth contracts, case studies and new deal data allows you to discover the benefits of early stage partnering and review the complex payment structures involved when making an early stage deal.

Updated with new data including case studies from 2006 and contracts this report aims to assist and guide leading professionals involved in business development through the complex process of early stage dealmaking.

Read this report to
- Discover the benefits of early stage partnering
- Examine the current partnering model
- Uncover ways to find the right partner
- Accumulate tips for structuring and maintaining the right deal
- Understand the cost differences between in-licensed projects and in-house pre-clinical projects

Report sections include
- Extensive selections of case studies from 2006, featuring companies such as Amgen, AstraZeneca and GlaxoSmithKline.
- A Comprehensive presentation of headline deal values at different phases of early stage development.
- Detailed company contracts, highlighting real values and information.

Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Discovery Stage Partnering Agreements in Biopharma

Pre-clinical Stage Partnering Agreements in Biopharma

Clinical Stage Partnering Agreements in Biopharma

Late Stage Deals: Strategy, Structure and Payment Terms

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics

Partneringreview 2006: Biopharma Deal Making By Development Stage - Early Stage: Discovery, Lead And Preclinical

Neurological Disease: Early-Stage R&D and Dealmaking

Early Contractor Involvement in Building Procurement: Contracts, Partnering and Project Management

Bigpharma Partnering Agreements

Partnering with Bigpharma: The Definitive Guide to Partnering Interests, Contacts & Agreements

Pharmaceutical Deal Structures - The Essential Manual for Deal Makers

YES Bank Case Study



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds